Boston Pharmaceuticals hits Phase 2 goals as it tries to keep up with MASH competitors

Boston Pharmaceuticals succeeded on two closely watched efficacy endpoints for its Phase 2 MASH study, putting the company in contention with other biotechs seeking to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cell Microsystems and OMNI Life Science Announce Strategic Partnership to Bring Innovative Cellular Analysis Solutions to North America

Cell Microsystems, a leading provider of advanced tools for cell biology, is excited to announce a strategic partnership with OMNI Life Science (OLS), a renowned

February 7, 2024

Experts Demand Overhaul of Organ Transplant System During Senate Hearing

Patients, advocates, and one rogue organ procurement organization (OPO) executive, among others, pledged support for legislation that aims to disrupt a decades-long monopoly over the

July 22, 2023

Vaping linked to respiratory issues in young adults

Researchers explore the association of respiratory illness based on self-reported symptoms among young adolescents who vaped.

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.